Izzedine H - Search Results

1

Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy.

Izzedine H, Mangier M, Ory V, Zhang SY, Sendeyo K, Bouachi K, Audard V, Péchoux C, Soria JC, Massard C, Bahleda R, Bourry E, Khayat D, Baumelou A, Lang P, Ollero M, Pawlak A, Sahali D. Izzedine H, et al. Kidney Int. 2014 Feb;85(2):457-70. doi: 10.1038/ki.2013.344. Epub 2013 Sep 25. Kidney Int. 2014. PMID: 24067439 Free article.

2

An appraisal of antiretroviral drugs in hemodialysis.

Izzedine H, Launay-Vacher V, Baumelou A, Deray G. Izzedine H, et al. Kidney Int. 2001 Sep;60(3):821-30. doi: 10.1046/j.1523-1755.2001.060003821.x. Kidney Int. 2001. PMID: 11532078 Free article. Review.

3

Renal effects of PPARalpha-agonists.

Izzedine H, Launay-Vacher V, Baumelou A, Deray G. Izzedine H, et al. Minerva Urol Nefrol. 2004 Dec;56(4):339-42. Minerva Urol Nefrol. 2004. PMID: 15785426 Review.

4

PPAR-gamma-agonists' renal effects.

Izzedine H, Launay-Vacher V, Buhaescu I, Heurtier A, Baumelou A, Deray G. Izzedine H, et al. Minerva Urol Nefrol. 2005 Dec;57(4):247-60. Minerva Urol Nefrol. 2005. PMID: 16247347 Review.

5

Drug-induced glomerulopathies.

Izzedine H, Launay-Vacher V, Bourry E, Brocheriou I, Karie S, Deray G. Izzedine H, et al. Expert Opin Drug Saf. 2006 Jan;5(1):95-106. doi: 10.1517/14740338.5.1.95. Expert Opin Drug Saf. 2006. PMID: 16370959 Review.

6

Make your diagnosis. Multiple myeloma-associated with spurious hyperphosphatemia.

Izzedine H, Camous L, Bourry E, Azar N, Leblond V, Deray G. Izzedine H, et al. Kidney Int. 2007 Oct;72(8):1035-6. doi: 10.1038/sj.ki.5002485. Kidney Int. 2007. PMID: 17914422 Free article. No abstract available.

7

Management of hypertension in angiogenesis inhibitor-treated patients.

Izzedine H, Ederhy S, Goldwasser F, Soria JC, Milano G, Cohen A, Khayat D, Spano JP. Izzedine H, et al. Ann Oncol. 2009 May;20(5):807-15. doi: 10.1093/annonc/mdn713. Epub 2009 Jan 15. Ann Oncol. 2009. PMID: 19150949 Free article. Review.

8

Proteinuria and proximal tubule lesions induced by an anti-integrin monoclonal antibody treatment: case report.

Gombos A, Izzedine H, Besse B, Massard C, Brocheriou I, Bahleda R, Soria JC. Gombos A, et al. Among authors: izzedine h. Invest New Drugs. 2010 Feb;28(1):102-5. doi: 10.1007/s10637-009-9247-3. Epub 2009 Apr 3. Invest New Drugs. 2010. PMID: 19343274

9

Acute left ventricular dysfunction induced by a panHER and VEGFR tyrosine kinase inhibitor in a phase I trial.

Bahleda R, Massard C, Soria JC, Izzedine H, Cohen A, Ederhy S. Bahleda R, et al. Among authors: izzedine h. Invest New Drugs. 2010 Jun;28(3):350-2. doi: 10.1007/s10637-009-9252-6. Epub 2009 Apr 25. Invest New Drugs. 2010. PMID: 19396400

10

QT interval prolongation among patients treated with angiogenesis inhibitors.

Ederhy S, Cohen A, Dufaitre G, Izzedine H, Massard C, Meuleman C, Besse B, Berthelot E, Boccara F, Soria JC. Ederhy S, et al. Among authors: izzedine h. Target Oncol. 2009 Apr;4(2):89-97. doi: 10.1007/s11523-009-0111-3. Epub 2009 May 6. Target Oncol. 2009. PMID: 19418112 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

272 results

Search Page

Filters